Picture loading failed.

Anti-CALCRL therapeutic antibody (Pre-made Erenumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Erenumab, sold under the brand name Aimovig, is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-193-1mg 1mg 3090
GMP-Bios-ab-193-10mg 10mg 21890
GMP-Bios-ab-193-100mg 100mg 148000
GMP-Bios-ab-193-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-CALCRL therapeutic antibody (Pre-made Erenumab biosimilar,Whole mAb)
INN Name Erenumab
TargetCALCRL
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCLambda
Highest_Clin_Trial (Jan '20)Approved
Est. StatusNFD
100% SI Structure6umh:HL/6umi:HL/6umj:HL
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2016
Year Recommended2017
CompaniesAmgen;Novartis
Conditions ApprovedMigraine
Conditions Activena
Conditions DiscontinuedHot flushes
Development TechAbgenix XenoMouse